Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Androstenedione/analogs & derivatives"'
BACKGROUND: Aromatase inhibitors and inactivators have been extensively tested in patients with advanced breast cancer, but it is unclear whether they offer any survival benefits compared with standard hormonal treatment with tamoxifen or progestagen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10561::9bc61b70921e64412e40f1ceaf410e73
http://olympias.lib.uoi.gr/jspui/handle/123456789/17948
http://olympias.lib.uoi.gr/jspui/handle/123456789/17948
Publikováno v:
The Journal of endocrinology. 156(2)
The presence of activins in those hypothalamic regions containing gonadotropin-releasing hormone (GnRH)-secreting neurons suggests that these peptides may regulate the reproductive function modulating not only pituitary FSH release and biosynthesis,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad3c96e128afd1ab9fbe8a0328a383b7
https://pubmed.ncbi.nlm.nih.gov/9518872
https://pubmed.ncbi.nlm.nih.gov/9518872
Publikováno v:
British Journal of Cancer
Plasma and urinary oestrogens were measured in nine breast cancer patients (eight postmenopausal women and one man) before and during treatment with the aromatase inhibitor 4-hydroxyandrostenedione. Urinary oestrogens were measured by using a highly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa3ee111983ee6d82381e31b452f5900
https://pubmed.ncbi.nlm.nih.gov/8135918
https://pubmed.ncbi.nlm.nih.gov/8135918